Global Health | Infectious Diseases | Physician practising in the tropical north of Australia | Clinical Researcher
#IDSky #malaria #vivax
https://www.menzies.edu.au/page/Our_People/Researchers/Ric_Price
Ric Price
Loading...
Modelling paper using data from prospective clinical trials highlights major impact of higher doses of primaquine and tafenoquine on P.vivax recurrences and #vivax transmission. Coverage, adherence and safety will be key elements in implementation.
www.thelancet.com/journals/lan...
We need facts as never before.
3 years after Putin invaded Ukraine, I spent 24 hours with combat medics on the Ukrainian frontline.
Their courage, compassion, dedication & skill are astounding.
Please read & please never stop standing up for Ukraine. 🇺🇦
www.theguardian.com/world/2025/f...
Are you researching #malaria? The datasets we host harmonise tens of thousands of individual patient data, enabling researchers to answer new questions from existing data. Learn more www.iddo.org/wwarn/w...
#DataReuse #DataForGood
Re-emergence of Oropouche virus in Brazil and Latin America www.thelancet.com/journals/lan...
Substantial reductions in prevalence as measured by PCR were predicted with primaquine
and tafenoquine regimens if these could be implemented with high coverage and adherence.
The benefits of preventi...
MALARIA MILESTONE | New research published today in The Lancet Infectious Diseases, has confirmed the safety & effectiveness of high-dose primaquine & single-dose tafenoquine in G6PD-normal patients in treating P. vivax #malaria. Read more: tinyurl.com/mw7edaup @kthriemer.bsky.social
📣 Medical editors call for #action against the decisions being taken in the #USA undermining #medicine and #science, and international #coordination to preserve what has been built across borders.
#IDSky #Clinmicro #MedSky #Episky #publichealth #vaccines
www.cmi-comms.com/article/S295...
More than half of the Gm-negative infections in soldiers in the Ukraine conflict are resistant to carbapenems - fascinating presentation on #AMR in conflict settings from @catanita.bsky.social
#antimicrobials2025 #ASA2025 #globalpublichealth #MDRI
Ric Price
Like the soldiers they battle to save, combat medics in Ukraine are under constant attack. Three years after the invasion, one NHS doctor bears witness
Clinical trial in Cambodia, once again highlighting that higher total doses of primaquine (7mg/kg) are needed to achieve high antirelapse cure rates in patients with #vivax malaria. Plus reassuring safety data.
www.medrxiv.org/content/10.1...
Understanding the factors affecting patient adherence to primaquine treatment will inform better interventions targeting #vivax radical cure. This study from Thai-Myanmar border provides great insights.
journals.plos.org/globalpublic...
Since early 2024, an unprecedented spread of the Oropouche virus has been observed
in Brazil and beyond in Latin America. Severe clinical consequences have been described,
including early reports of d...
The most anticipated RCT in ID
🔥SNAP RCT🔥The largest RCT 2 date in SA bactermia
N:1341
Cefazolin Vs ASPs ((flu)cloxacillin) for MSSA bacteremia
Cefazolin is non-inferior (90d mortality)& less AKI than ASPs
A practice-changer RCT that must change the guidelines
#ESCMIDGlobal #IDSky
Each time a man stands up for an ideal, or acts to improve the lot of others, or strikes
out against injustice, he sends forth a tiny ripple of hope.Robert F. Kennedy, Senior
Background The WHO malaria treatment guidelines recommend a total dose in the range of 3·5 to 7·0 mg/kg of primaquine to eliminate Plasmodium vivax ( P. vivax ) hypnozoites and prevent relapses. There...
www.medrxiv.org
Menzies School of Health Research
Background The countries within the Greater Mekong Region of Southeast Asia have pledged to eliminate malaria by 2030. Elimination of Plasmodium vivax malaria is challenging as it requires radical cur...
